The most striking finding is the 110.2% YTD gain versus the S&P's 86.5%, which signals that CMPR is delivering superior total shareholder returns through both price appreciation and potentially higher earnings multiples, making it a compelling relative performer for growth‑oriented portfolios.
A key caution is the near‑flat ten‑year annualized return (-0.6%) despite strong recent performance; this indicates that past volatility and periods of underperformance could re‑emerge if growth slows or macro pressures compress margins, potentially eroding the 24.9% three‑year streak.
Insider activity shows a net sell ratio of 0.72, meaning insiders have sold roughly 28% more shares than they bought; combined with a recent 1.31% institutional outflow, this divergence could foreshadow concerns about near‑term earnings momentum and warrants close monitoring.
The divergence between the 5.6% three‑year CAGR and the current 3.38% YoY growth is the most striking finding; it flags a deceleration that could pressure valuation multiples unless the company re‑accelerates through new product launches or geographic expansion.
The net margin of only 0.4% represents a fragile profit base; a 10‑basis‑point increase in fulfillment costs would wipe out earnings entirely, exposing the company to heightened risk if cost efficiencies do not materialize.
The margin plunge to 0.4% is the pivotal driver of the ROE reversal, revealing that core operations are no longer profitable and any future upside will require a turnaround in cost control or pricing power before leverage can be leveraged positively again.
| Year | ROE% | Margin% | Turnover | Leverage | ROIC% | ROCE% | ROA% |
|---|---|---|---|---|---|---|---|
| 2025 | -2.6 | 0.4 | 1.73 | -3.37 | 20.2 | 18.7 | 0.8 |
| 2024 | -31.6 | 5.3 | 1.74 | -3.44 | 22.6 | 20.1 | 9.2 |
| 2023 | 29.8 | -6.0 | 1.66 | -2.98 | 5.0 | 4.7 | -10.0 |
| 2022 | 11.0 | -1.9 | 1.33 | -4.38 | 3.6 | 3.2 | -2.5 |
| 2021 | 19.0 | -3.3 | 1.18 | -4.86 | 9.4 | 8.0 | -3.9 |
| 2020 | -20.5 | 3.4 | 1.37 | -4.45 | 4.8 | 4.2 | 4.6 |
| 2019 | 72.1 | 3.5 | 1.47 | 14.17 | 13.0 | 12.1 | 5.1 |
| 2018 | 46.7 | 1.7 | 1.57 | 17.64 | 15.0 | 13.5 | 2.6 |
| 2017 | -95.6 | -3.4 | 1.27 | 22.40 | -4.0 | -3.7 | -4.3 |
| 2016 | 32.8 | 3.0 | 1.22 | 8.83 | 7.3 | 6.9 | 3.7 |
| 2015 | 37.0 | 6.2 | 1.14 | 5.26 | 10.1 | 9.6 | 7.0 |
The negative cash conversion cycle of -37 days, while boosting short‑term liquidity, masks a risk that suppliers could demand tighter credit or higher prices if payment terms become unsustainable, which would further pressure the already thin 0.4% margin and jeopardize the durability of the 20.2% ROIC.
| Year | Total Asset Days | Inventory Days | Receivables Days | Fixed Asset Days | Payables Days | Cash Conversion Cycle |
|---|---|---|---|---|---|---|
| 2025 | 211 | 23 | 7 | 41 | 68 | -37 |
| 2024 | 210 | 21 | 7 | 38 | 70 | -42 |
| 2023 | 220 | 24 | 8 | 43 | 64 | -32 |
| 2022 | 274 | 31 | 8 | 46 | 77 | -38 |
| 2021 | 309 | 20 | 7 | 59 | 56 | -29 |
| 2020 | 267 | 23 | 5 | 73 | 48 | -19 |
| 2019 | 248 | 17 | 8 | 65 | 48 | -23 |
| 2018 | 233 | 17 | 8 | 68 | 43 | -18 |
| 2017 | 287 | 16 | 8 | 88 | 45 | -20 |
| 2016 | 299 | 9 | 7 | 101 | 41 | -26 |
| 2015 | 320 | 12 | 8 | 114 | 42 | -23 |
| Year | Total Assets | Total Liabilities | Total Equity | Total Debt | Net Debt | Cash | Current Assets | Current Liabilities |
|---|---|---|---|---|---|---|---|---|
| 2025 | $1968M | $2532M | $-583M | $1707M | $1473M | $234M | $503M | $759M |
| 2024 | $1892M | $2409M | $-550M | $1722M | $1518M | $204M | $458M | $664M |
| 2023 | $1855M | $2467M | $-623M | $1757M | $1627M | $130M | $441M | $645M |
| 2022 | $2168M | $2531M | $-495M | $1793M | $1515M | $277M | $626M | $693M |
| 2021 | $2182M | $2561M | $-449M | $1886M | $1703M | $183M | $528M | $638M |
| 2020 | $1815M | $2153M | $-407M | $1631M | $1586M | $45M | $248M | $487M |
| 2019 | $1868M | $1673M | $132M | $1175M | $1140M | $35M | $240M | $521M |
| 2018 | $1652M | $1472M | $94M | $970M | $926M | $44M | $239M | $481M |
| 2017 | $1680M | $1559M | $75M | $983M | $958M | $26M | $246M | $449M |
| 2016 | $1464M | $1232M | $166M | $831M | $753M | $77M | $201M | $336M |
| 2015 | $1308M | $1001M | $249M | $616M | $513M | $104M | $218M | $307M |
| Year | Operating CF | Investing CF | Financing CF | CapEx | Free Cash Flow | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| 2025 | $298M | $-141M | $-136M | $-153M | $145M | $-78M | |
| 2024 | $351M | $-55M | $-223M | $-55M | $296M | $-157M | |
| 2023 | $130M | $-104M | $-177M | $-112M | $19M | ||
| 2022 | $220M | $-4M | $-107M | $-119M | $100M | $-3M | |
| 2021 | $265M | $-354M | $224M | $-99M | $166M | $-2M | |
| 2020 | $338M | $-67M | $-258M | $-94M | $244M | $-627M | |
| 2019 | $331M | $-420M | $82M | $-119M | $212M | $-56M | |
| 2018 | $192M | $-11M | $-178M | $-102M | $90M | $-95M | |
| 2017 | $157M | $-302M | $105M | $-112M | $45M | $-50M | |
| 2016 | $247M | $-266M | $-5M | $-107M | $140M | $-153M | |
| 2015 | $229M | $-217M | $25M | $-93M | $135M | $-0M |
This report is generated by Finexus and is provided for informational purposes only. It does not constitute investment advice, a recommendation, or an offer or solicitation to buy or sell any security.
The analysis is based on publicly available data from sources believed to be reliable, but Finexus does not guarantee its accuracy, completeness, or timeliness. Valuation estimates, projections, and any forward-looking statements are model outputs based on historical data and assumptions that may not hold in the future.
Past performance is not indicative of future results. Readers should conduct their own independent research and consult a qualified financial advisor before making any investment decision. Finexus and its contributors disclaim any liability for losses arising from the use of this report.
Created 2026-06-07 · finexus.net